Comparison of Thrice-daily Novomix Insulin Versus Insulin Glargine Once-Daily Combined with Thrice-Daily Insulin Aspart on Glycemic Control in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study

نویسندگان
Mirtorabi, Seyyed Hossein ID 1
Razavi, Roghaye ID 2
Namiranian, Nasim ID 3
Modarresi, Mozhgan ID 4
Mirjalili, Roghaye ID 5
Azizi, Reyhaneh ID 6

1 MD,Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

2 Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

3 Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

4 Assistant Professor of Community & Preventive Medicine, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

5 Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

6 Assistant Professor of endocrinology, Yazd Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

doi
چکیده

Objective: The objective of the present analysis was to compare the effect of these two treatment regimens (Novomix insulin twice or thrice-daily versus once-daily insulin glargine plus twice or thrice-daily insulin aspart) on glycemic control in Iranian patients with T2DM. Materials and Methods: This cross-sectional study was conducted for one ...

کلیدواژه‌ها
Insulin aspart, Insulin Glargine, Glycemic control, Diabetes mellitus, type 2.